MarketInOut Stock Screener Log In | Sign Up

Parnax Lab Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Parnax Lab Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization1,284.67 mln
Float2.85 mln

EPS

7.79
Strong

P / E

13.93
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.05
Caution advised

Relative Strength

32 / 100
Underperforming

Debt / Equity

0.87
Moderate leverage

Business Description

Founded in 1982 and based in Mumbai, India, Parnax Lab Limited makes and sells a wide range of medicines, health supplements, herbal remedies, and cosmetic products to customers both within India and abroad. The company produces these in many forms, including tablets, capsules, liquids, creams, and gels, covering treatments for areas such as coughs, digestion, allergies, and nutritional needs. Parnax Lab also helps other businesses by offering drug research, product development, and contract manufacturing services.

Key Fundamentals

EPS7.79
P/E13.93
ROE10.01
RPS220
ROIC6.25
ROA4.29
Interest Cover2.58
EBITDA, mln265
EV / EBITDA7.99
EV / EBIT11.65
Revenue, mln2,520
EV / Revenue0.84

Quote Details

Last 108.50
Change 5 (4.83%)
Open 98.05
Volume 62
Turnover 6,727
Average Volume 1,279.38

Financial Ratios

Pre-Tax Profit Margin5
Current Ratio0.95
Price / Book1.34
Price / Tangible Book1.35
Debt / Equity0.87
Price / Sales0.51
PEG Ratio1.33

Financial Strength

Altman Z-Score2.35
Piotroski F-Score 6 / 9
Beneish M-Score-2.05
Price to Lynch Fair Value2.00
Price to Graham Number0.80

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.65% 35 / 100   
1 Month -15.7% 17 / 100   
2 Months -26.24% 11 / 100   
6 Months -30.72% 13 / 100   
1 Year -15.89% 53 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog